Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Pharmaindustrie / Medikamente
  • Schmerzen / Migräne / Analgetika
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bosnien-Herzegowina
  • Bulgarien
  • Dänemark
  • Deutschland
  • Estland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Italien
  • Kroatien
  • Lettland
  • Litauen
  • Mazedonien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Serbien
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vereinigtes Königreich
  • Weißrussland
  • Weißrussland
  • Asien / Pazifik
  • China
  • Hong Kong
  • Indien
  • Indonesien
  • Japan
  • Kasachstan
  • Malaysia
  • Neuseeland
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Usbekistan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Algerien
  • Iran
  • Israel
  • Kamerun
  • Kenia
  • Marokko
  • Nigeria
  • Saudi Arabien
  • South Africa
  • Tunesien
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Bolivien
  • Brasilien
  • Chile
  • Costa Rica
  • Kolumbien
  • Mexiko
  • Peru
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • Biopharm Reports
  • Canadean
  • Datamonitor
  • Euromonitor
  • GBI Research
  • Global Markets Direct
  • GlobalData
  • Life Science Analytics
  • Technavio
  • Filter zurücksetzen
Sprache
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • Filter zurücksetzen
laedt

Marktanalyse - Analgesics in Iran

Euromonitor

Euromonitor

8 / 2012
26 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: Iran
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

675,00 €*
PDF-Datei per E-Mail , versandkostenfrei


Due to the widespread consumption of RX analgesics products without prescription, consumption of analgesics is estimated to be much higher than the data projected in Euromonitor database (Euromonitor only covers OTC analgesics). It is common practice for Iranian consumers to obtain RX analgesics without prescription, even though, on paper, it is illegal. According to the Iranian Ministry of Health and Hygiene’s database, codeine acetaminophen (Rx) sales were almost two and a half times higher...

Euromonitor International's Analgesics in Iran report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
ANALGESICS IN IRAN

Euromonitor International

August 2012



LIST OF CONTENTS AND TABLES



Headlines

Trends

Switches

Competitive Landscape

Prospects

Category Data

Table 1 Sales of Analgesics by Category: Value 2006-2011

Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011

Table 3 Analgesics Company Shares 2007-2011

Table 4 Analgesics Brand Shares 2008-2011

Table 5 Forecast Sales of Analgesics by Category: Value 2011-2016

Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Darou Pakhsh Pharmaceutical Mfg Co in Consumer Health (iran)

Strategic Direction

Key Facts

Summary 1 Darou Pakhsh Pharmaceutical MFG Co: Key Facts

Summary 2 Darou Pakhsh Pharmaceutical MFG Co: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 3 Darou Pakhsh Pharmaceutical MFG: Competitive Position 2011

Dr Abidi Pharmaceutical Co in Consumer Health (iran)

Strategic Direction

Key Facts

Summary 4 Dr Abidi Pharmaceutical Co: Key Facts

Summary 5 Dr Abidi Pharmaceutical Co: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 6 Dr Abidi Pharmaceutical Co: Competitive Position 2011

Executive Summary

Consumer Health Sustains Healthy Growth in 2011 But at A Slower Pace

Economic and Political Factors Threaten Both Importers and Manufacturers

Increasing Availability of Imported Vitamins and Dietary Supplements

Distribution Mainly Only Allowed Through Chemists/pharmacies

Reduced Subsidies To Have A Significant Impact on Unit Price and Consumption

Key Trends and Developments

Major Turmoil for the Iranian Economy

Huge Young Iranian Population Remains the Main Growth Driver

Pharmacies Remain the Main Distribution Channel

Strong Influence of Self-medication and Utc Consumption

Brand Awareness of OTC Remains Limited, Unlike Vds

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011

Table 8 Life Expectancy at Birth 2006-2011

Market Data

Table 9 Sales of Consumer Health by Category: Value 2006-2011

Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011

Table 11 Consumer Health Company Shares 2007-2011

Table 12 Consumer Health Brand Shares 2008-2011

Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011

Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010

Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016

Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

Definitions

Sources

Summary 7 Research Sources

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: